    <SEC-DOCUMENT>0001493152-24-016976-index.html : 20240429
    <SEC-HEADER>0001493152-24-016976.hdr.sgml : 20240429
    <ACCEPTANCE-DATETIME>20240429161533
    ACCESSION NUMBER:		0001493152-24-016976
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20231231
    FILED AS OF DATE:		20240429
    DATE AS OF CHANGE:		20240429
    EFFECTIVENESS DATE:		20240429

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			GT Biopharma, Inc.
    		CENTRAL INDEX KEY:			0000109657
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				941620407
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-40023
    		FILM NUMBER:		24890977

    	BUSINESS ADDRESS:
    		STREET 1:		8000 MARINA BLVD
    		STREET 2:		SUITE 100
    		CITY:			BRISBANE
    		STATE:			CA
    		ZIP:			94005
    		BUSINESS PHONE:		(800) 304-9888

    	MAIL ADDRESS:
    		STREET 1:		8000 MARINA BLVD
    		STREET 2:		SUITE 100
    		CITY:			BRISBANE
    		STATE:			CA
    		ZIP:			94005

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	OXIS INTERNATIONAL INC
    		DATE OF NAME CHANGE:	19940916

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
    		DATE OF NAME CHANGE:	19920703

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
    		DATE OF NAME CHANGE:	19850312
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>formars.pdf
    <TEXT>
    Document 1 - file: formars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>